About

Basalog contains Insulin Glargine, a long-acting human insulin analog designed to provide a steady, peakless basal insulin level over 24 hours. It is used to improve glycemic control in adults and children with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. Insulin Glargine works by replacing the insulin that the body would normally produce, helping glucose move from the blood into body cells for energy. Its prolonged duration of action allows for once-daily administration, typically at the same time each day, providing consistent blood glucose lowering effects and reducing the risk of nocturnal hypoglycemia compared to intermediate-acting insulins. Careful monitoring of blood glucose levels is essential to adjust the dose and prevent both hyperglycemia and hypoglycemia.

Uses

Management of type 1 diabetes mellitus.
Management of type 2 diabetes mellitus.
To achieve long-term glycemic control.
To reduce fasting and postprandial blood glucose levels.

Directions For Use

Administer subcutaneously once daily at the same time each day. Do not administer intravenously.

Benefits

Provides 24-hour basal insulin coverage.
Reduces risk of nocturnal hypoglycemia.
Offers consistent blood glucose control.
Convenient once-daily dosing.
Helps prevent long-term diabetes complications.
Improves overall glycemic management.

Side Effects

Hypoglycemia (low blood sugar)
Injection site reactions (pain, redness, swelling)
Lipodystrophy (fat tissue changes at injection site)
Weight gain
Peripheral edema
Allergic reactions (rare)
Pruritus (itching)
Rash
Urticaria (hives)
Flu-like symptoms
Headache
Nausea

Safety Measures

Alcohol - Alcohol can lower blood sugar and increase the risk of hypoglycemia when used with insulin. Consume in moderation or avoid.
Pregnancy - Generally considered safe for use during pregnancy to manage gestational or pre-existing diabetes. Close monitoring is essential.
Breastfeeding - Insulin is not excreted into breast milk and is considered safe for use during breastfeeding.
Liver - Dose adjustments may be necessary in patients with severe hepatic impairment due to altered insulin metabolism.
Kidney - Dose adjustments may be required in patients with renal impairment due to reduced insulin clearance.
Lung - No specific contraindications or precautions related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location